Multidrug-resistant viridans streptococcus (MDRVS) osteomyelitis of the mandible successfully treated with moxifloxacin

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

Multidrug-resistant viridans group streptococcus (MDRVS) strains have emerged as important pathogens. Treatment of MDRVS infections is problematic. The use of fluoroquinolones for treatment of MDRVS osteomyelitis has not been established. We present the first case of MDRVS osteomyelitis of the mandible successfully treated with sequential intravenous then oral moxifloxacin, and review the literature on the subject.

Original languageEnglish
Pages (from-to)539-540
Number of pages2
JournalSouthern Medical Journal
Volume101
Issue number5
DOIs
StatePublished - May 2008

Keywords

  • Mandible
  • Moxifloxacin
  • Multidrug-resistant viridans streptococcus (MDRVS)
  • Osteomyelitis

Fingerprint

Dive into the research topics of 'Multidrug-resistant viridans streptococcus (MDRVS) osteomyelitis of the mandible successfully treated with moxifloxacin'. Together they form a unique fingerprint.

Cite this